Semaglutide is a GLP-1 receptor agonist with engineered albumin-binding side chain and protease-resistant modifications, extensively documented in medicinal chemistry and pharmacology literature. This 20mg preparation supports mid-scale research protocols studying GLP-1 receptor pharmacology in cell-based and systems-level experimental designs.
Compound Profile
- Class: GLP-1 receptor agonist (long-acting analog)
- Form: Lyophilized peptide, sealed Type I borosilicate vial
- Engineered features: Albumin-binding side chain, protease-resistant backbone modifications
- Net content: 20 mg / vial
Quality & Documentation
- Purity: ≥99% verified by reverse-phase HPLC
- Identity: Confirmed by mass spectrometry
- Certificate of Analysis: Batch-specific, lot-traceable, available on request
- Manufacturing: Controlled conditions, independent per-batch analytical testing
- Storage: Refrigerate at 36–46°F lyophilized; ~60 day stability reconstituted
Research Use
Designated for research use only. Not for human consumption, veterinary administration, dietary supplementation, or food-additive application.
